WFG Advisors’s iShares US Medical Devices ETF IHI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$40K Hold
1,452
0.01% 752
2017
Q1
$37K Sell
1,452
-2,712
-65% -$65.8K 0.01% 739
2016
Q4
$92K Buy
4,164
+60
+1% +$1.36K 0.02% 541
2016
Q3
$99K Buy
4,104
+96
+2% +$2.28K 0.02% 521
2016
Q2
$91K Buy
4,008
+2,286
+133% +$49.5K 0.02% 524
2016
Q1
$35K Hold
1,722
0.01% 760
2015
Q4
$35K Buy
1,722
+942
+121% +$18.9K 0.01% 755
2015
Q3
$14K Sell
780
-150
-16% -$3.02K ﹤0.01% 997
2015
Q2
$19K Buy
930
+780
+520% +$15.6K 0.01% 994
2015
Q1
$3K Sell
150
-10,710
-99% -$209K ﹤0.01% 1478
2014
Q4
$205K Buy
10,860
+10,200
+1,545% +$184K 0.04% 420
2014
Q3
$11K Sell
660
-114
-15% -$1.94K ﹤0.01% 1468
2014
Q2
$13K Sell
774
-966
-56% -$15.8K ﹤0.01% 1410
2014
Q1
$29K Buy
1,740
+960
+123% +$15.4K 0.01% 1109
2013
Q4
$12K Buy
780
+666
+584% +$9.93K ﹤0.01% 1520
2013
Q3
$2K Buy
+114
New +$1.57K ﹤0.01% 1933

Other funds holding IHI

WFG Advisors's IHI Position: Q2 2017 in Review

WFG Advisors held its iShares US Medical Devices ETF (IHI) position steady in Q2 2017 at 1,452 shares worth $40K. The position accounts for 0.01% of the portfolio, ranked #752.

WFG Advisors first reported a position in IHI in Q3 2013 and has held it in 16 quarters since. The position peaked at $205K in Q4 2014. 160 funds tracked by Wall St. Rank hold IHI as of Q2 2017.

  • WFG Advisors held 1,452 shares of iShares US Medical Devices ETF worth $40K as of Q2 2017.
  • WFG Advisors left its iShares US Medical Devices ETF share count unchanged in Q2 2017.
  • iShares US Medical Devices ETF made up 0.01% of WFG Advisors's portfolio in Q2 2017, its #752 holding.
  • WFG Advisors first reported a position in iShares US Medical Devices ETF in Q3 2013 and has held it in 16 quarters since.
  • WFG Advisors's iShares US Medical Devices ETF position peaked at $205K in Q4 2014.
  • 160 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2017.

Based on WFG Advisors's 13F filing for Q2 2017, filed 18 Aug 2017.